Grzelecki Dariusz, Grajek Aleksandra, Dudek Piotr, Olewnik Łukasz, Zielinska Nicol, Fulin Petr, Czubak-Wrzosek Maria, Tyrakowski Marcin, Marczak Dariusz, Kowalczewski Jacek
Department of Orthopedics and Rheumoorthopedics, Centre of Postgraduate Medical Education, Professor Adam Gruca Orthopedic and Trauma Teaching Hospital, Konarskiego 13, 05-400 Otwock, Poland.
Central Laboratory of Professor Adam Gruca Orthopedic and Trauma Teaching Hospital, Konarskiego 13, 05-400 Otwock, Poland.
J Fungi (Basel). 2022 Jul 29;8(8):797. doi: 10.3390/jof8080797.
The aim of this study was to analyze the treatment results of fungal periprosthetic joint infections (PJI) caused by species from a single orthopedic center and to compare them with reports from other institutions.
Eight patients operated on from January 2014 to December 2021 met the inclusion criteria and were analyzed in terms of clinical outcomes. A systematic review of the literature identified 153 patients with PJIs extracted from 12 studies according to the PRISMA (Preferred Reporting Item for Systematic Reviews and Meta-Analyses) guidelines.
The success rate of the treatment in the case series was 50%. The most frequent pathogens were (three cases; 37.5%) and (three cases; 37.5%). In one patient (12.5%), bacterial co-infection was noted, and in five patients (62.5%) significant risk factors of PJI were confirmed. The overall success rate on the basis of data collected for systematic review was 65.5%. A sub-analysis of 127 patients revealed statistically significant differences ( = 0.02) with a higher success rate for the knees (77.6%) than for the hips (58%). In 10 studies the analysis of risk factors was performed and among 106 patients in 77 (72.6%) comorbidities predispose to fungal PJI were confirmed. Bacterial co-infection was noted in 84 patients (54.9%). In 93 patients (60.7%) was the culprit pathogen, and in 39 patients (25.5%) was the culprit pathogen. Based on these two most frequent species causing PJI, the success rate of the treatment was statistically different ( = 0.03), and was 60.3% and 83.3%, respectively. The two-stage strategy was more favorable for patients with infections (94.4% success rate) than the one-stage protocol (50% success rate; = 0.02); as well as in comparison to the two-stage treatment of (65% success rate; = 0.04).
The analysis of the literature showed no differences in the overall success rate between one- and two-stage surgical strategies for all species, but differed significantly comparing the two most frequent strains and concerning PJI localization. The frequent presence of bacterial co-infections makes it necessary to consider the additional administration of antibiotics in the case of fungal PJI.
本研究旨在分析某单一骨科中心由特定菌种引起的真菌性人工关节周围感染(PJI)的治疗结果,并与其他机构的报告进行比较。
2014年1月至2021年12月接受手术的8例患者符合纳入标准,并对其临床结果进行分析。根据PRISMA(系统评价和Meta分析的首选报告项目)指南,对文献进行系统评价,从12项研究中提取出153例PJI患者。
该病例系列的治疗成功率为50%。最常见的病原体是[具体菌种1](3例;37.5%)和[具体菌种2](3例;37.5%)。1例患者(12.5%)存在细菌合并感染,5例患者(62.5%)确诊为PJI的显著危险因素。基于系统评价收集的数据得出的总体成功率为65.5%。对127例患者的亚分析显示,膝关节(77.6%)的成功率高于髋关节(58%),差异有统计学意义(P = 0.02)。10项研究进行了危险因素分析,在106例患者中,77例(72.6%)确诊存在易导致真菌性PJI的合并症。84例患者(54.9%)存在细菌合并感染。93例患者(60.7%)的致病病原体为[具体菌种1],39例患者(25.5%)的致病病原体为[具体菌种2]。基于这两种最常见的引起PJI的菌种,治疗成功率有统计学差异(P = 0.03),分别为60.3%和83.3%。两阶段策略对[具体菌种1]感染患者(成功率94.4%)比一阶段方案(成功率50%;P = 0.02)更有利;与[具体菌种2]的两阶段治疗相比(成功率65%;P = 0.04)也是如此。
文献分析表明,对于所有菌种,一阶段和两阶段手术策略的总体成功率无差异,但在比较两种最常见菌株以及PJI的部位时存在显著差异。细菌合并感染的频繁出现使得在真菌性PJI病例中考虑额外使用抗生素成为必要。